Life Science REIT (LON:LABS – Free Report) had its price target reduced by Jefferies Financial Group from GBX 45 ($0.59) to GBX 36 ($0.47) in a report released on Friday morning, LSE.Co.UK reports. They currently have a hold rating on the stock.
Life Science REIT Stock Performance
Shares of LON:LABS opened at GBX 34 ($0.45) on Friday. The stock has a market capitalization of £119.00 million, a price-to-earnings ratio of -565.83 and a beta of 0.07. Life Science REIT has a 1-year low of GBX 32.20 ($0.42) and a 1-year high of GBX 76.80 ($1.01). The company has a 50 day moving average price of GBX 34.15 and a 200 day moving average price of GBX 37.74.
Recommended Stories
- Five stocks we like better than Life Science REIT
- Want to Profit on the Downtrend? Downtrends, Explained.
- The Solar Stock Battle: Is Daqo or JinkoSolar Your Next Big Win?
- Retail Stocks Investing, Explained
- Are These Chinese Stocks a Buy? Michael Burry’s Top Picks Say Yes
- Why Are These Companies Considered Blue Chips?
- Five Below Stock Faces Challenges Despite Strong Revenue Growth
Receive News & Ratings for Life Science REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Life Science REIT and related companies with MarketBeat.com's FREE daily email newsletter.
